Evidence map›Paper›PMID 35219433›Full record

ReviewThe Psychiatric clinics of North America2022

The Impact of COVID-19 on Brain Stimulation Therapy.

Michael Justin Coffey, Suzanne Kerns, Sohag Sanghani, Lee Wachtel

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Psychiatric clinics of North America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Michael Justin CoffeyGeisinger Health System, 100 N Academy Ave, Danville, PA 17822, USA. Electronic address: jcoffey1@geisinger.edu.
Suzanne KernsMedical University of South Carolina, Charleston, SC, USA.
Sohag SanghaniZucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Lee WachtelKennedy Krieger Institute, Baltimore, MD, USA.
Geisinger Health System · USHofstra University · USKennedy Krieger Institute · USMedical University of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the far-reaching effects of the COVID-19 pandemic has been restricted access to safe and effective forms of psychiatric treatment. Focusing on electroconvulsive therapy and transcranial magnetic stimulation, we review the pandemic's impact on brain stimulation therapy by asking 3 fundamental questions-Where have we been? How are we doing? And where are we going?

Indexed as

COVID-19Electroconvulsive TherapyBrainHumansPandemicsSARS-CoV-2Transcranial Magnetic StimulationAccess to careBrain stimulationCOVID-19Electroconvulsive therapy (ECT)Transcranial magnetic stimulation (TMS)

Identifiers

PMID35219433
PMCPMC8801771
OpenAlexW3213915319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.